Andrew is a seasoned litigator with more than 15 years of experience in complex commercial litigation, white collar defense, and government investigations involving the False Claims Act, Anti-Kickback Statute, Controlled Substances Act, Bank Secrecy Act, FTCA, immigration, and employment matters.
Before joining Vedder, Andrew served as an Assistant United States Attorney and Healthcare Fraud Coordinator for the Northern District of Texas. In that role, Andrew led multiple consequential False Claims Act and Controlled Substances Act investigations and civil enforcement actions, including matters involving healthcare fraud, kickbacks, drug diversion, pandemic relief fraud, and defense contracting issues. He also handled a broad range of defensive matters for the federal government, including employment disputes, immigration challenges, and FTCA litigation, managing all aspects of cases from intake through trial.
Andrew is known for his collegial yet aggressive, principled, and practical approach to navigating government scrutiny with clarity and efficiency. His experience on both the enforcement and defense sides allows him to anticipate how agencies operate and guide companies, executives, and professionals through high-stakes investigations and disputes while keeping business priorities at the forefront.
Credentials
Education
- Emory University School of Law, J.D., 2009
- Vanderbilt University, B.S., 2004
Bar Admissions
- Texas, 2026
- New York, 2010
Insights & Events
Publications
DOJ Announces Landmark Settlement with Texas Children’s Hospital and Intent to “Use Every Weapon at Its Disposal” to End Gender-Affirming Care for Minors
May 19, 2026
Speaking Engagements
Andrew Robbins, Jeff Ansley, Arianna Goodman, and Adam Farrell to Participate in 2026 Northern District of Texas Bench Bar Conference
April 24, 2026
Speaking Engagements
Andrew Robbins to Present on Healthcare FCA Enforcement at HCCA Dallas Regional Healthcare Compliance Conference
February 12, 2026
News
Vedder Price Expands Dallas Office with Addition of Former Federal Prosecutor Andrew S. Robbins
November 18, 2025
